Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia | Zendy

Suresh H. Advani | Zendy; Suvarna Achreckar | Zendy; Dennis Thomas | Zendy; Binny Krishnankutty | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia

Author(s) -

Suresh H. Advani,

Suvarna Achreckar,

Dennis Thomas,

Binny Krishnankutty

Publication year - 2010

Publication title -

indian journal of medical and paediatric oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.229

H-Index - 22

eISSN - 0975-2129

pISSN - 0971-5851

DOI - 10.4103/0971-5851.73590

Subject(s) - filgrastim , medicine , neutropenia , febrile neutropenia , chemotherapy , granulocyte colony stimulating factor , absolute neutrophil count , antibiotics , surgery , microbiology and biotechnology , biology

The use of granulocyte colony-stimulating factors to treat patients with chemotherapy-induced neutropenia is well accepted. To assess whether administration of filgrastim along with standard empiric antibiotic therapy is beneficial for patients with chemotherapy-induced febrile neutropenia (FN), we conducted an open, non-randomized clinical trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research